Please wait while we open this resource.
K
Clinical reviews
CENTRAL VENOUS PRESSURE REVISITED: PHYSIOLOGY, PITFALLS, MISCONCEPTIONS, AND MODERN CLINICAL INTERPRETATION IN CRITICAL CARE
Department of Medical Science, Surgery and Neurosciences, University Hospital of Siena; Department of Intensive Care, Hôpital Universitaire de Bruxelles
PDF18 pages2.6 MB
Central venous pressure (CVP) has traditionally been used as a marker of intravascular volume and cardiac preload. However, recent evidence suggests that its utility as a fixed target for fluid resuscitation is diminishing. This narrative review traces the historical context of CVP interpretation and emphasizes the need for a multimodal approach to hemodynamic assessment, integrating CVP with other techniques such as venous excess ultrasound (VExUS) to better evaluate patient fluid status and organ perfusion.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
LEFT VENTRICULAR-ARTERIAL COUPLING IN SEPTIC SHOCK: A PHYSIOLOGICAL REVIEW
Same clinical topic · Critical Care
HOW I PERSONALIZE FLUID THERAPY IN SEPTIC SHOCK?
Same clinical topic · Critical Care
PRINCIPLES OF FLUID MANAGEMENT
Same clinical topic · Critical Care
ANEMIA OF CRITICAL ILLNESS: A CONCISE DEFINITIVE REVIEW IN CRITICAL CARE
Same clinical topic · Critical Care
NON-INTERVENTIONAL FOLLOW-UP VERSUS FLUID BOLUS IN RESPONSE TO OLIGURIA IN HEMODYNAMICALLY STABLE CRITICALLY ILL PATIENTS: A RANDOMIZED CONTROLLED PILOT TRIAL
Same clinical topic · Critical Care
LONG-TERM EFFECTS OF RESTRICTION OF INTRAVENOUS FLUID IN ADULT ICU PATIENTS WITH SEPTIC SHOCK
Same clinical topic · Critical Care
ASSOCIATION BETWEEN COMBINATION ANTIBIOTIC THERAPY AS OPPOSED TO MONOTHERAPY AND OUTCOMES OF ICU PATIENTS WITH PSEUDOMONAS AERUGINOSA VENTILATOR-ASSOCIATED PNEUMONIA: AN ANCILLARY STUDY OF THE IDIAPASON TRIAL
Same clinical topic · Critical Care
INTERFERON GAMMA - 1B FOR THE PREVENTION OF HOSPITAL - ACQUIRED PNEUMONIA IN CRITICALLY ILL PATIENTS: A PHASE 2, PLACEBO - CONTROLLED RANDOMIZED CLINICAL TRIAL
Same clinical topic · Critical Care
MANAGING THE PHYSIOLOGICALLY DIFFICULT AIRWAY IN CRITICALLY ILL ADULTS
Same clinical topic · Critical Care